Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Insidens dan Tatalaksana Penyakit Serebrovaskular

Penulis

  • Billy Priyanto Hamidjoyo Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia
  • Budi Riyanto Wreksoatmodjo Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i8.109

Kata Kunci:

penyakit serebrovaskular, COVID-19, stroke

Abstrak

COVID-19 dikenal dengan manifestasi klinis terkait saluran pernapasan seperti batuk, sesak, dan demam. Namun, saat ini telah banyak diteliti bahwa COVID-19 dapat menimbulkan gejala di luar sistem pernapasan, salah satunya ke sistem saraf. Pelaporan kejadian stroke pada pasien COVID-19 masih bervariasi, namun pada pasien COVID-19, khususnya yang bergejala berat terdapat kondisi hiperkoagulasi yang dapat menyebabkan komplikasi trombotik seperti trombosis vena dalam dan diduga berkaitan dengan risiko stroke pada pasien COVID-19.

COVID-19 is known for its clinical manifestations related to the respiratory tract such as cough, shortness of breath, and fever. However, currently it has been widely studied that COVID-19 can cause symptoms outside the respiratory system, one of which is the nervous system. Reports of stroke events in COVID-19 patients still vary, but in COVID-19 patients, especially those with severe symptoms, there is a hypercoagulable condition that can cause thrombotic complications such as deep vein thrombosis and is thought to be associated with the risk of stroke in COVID-19 patients.

Unduhan

Data unduhan belum tersedia.

Referensi

World Health Organization. Coronavirus Disease 2019 Situation Report-1. 2020.

World Health Organization. Coronavirus Disease 2019 Situation Report-46. 2021.

Al Samman M, Caggiula A, Ganguli S, Misak M, Pourmand A. Non-respiratory presentations of COVID-19, a clinical review. Am J Emergency Med. 2020;38(11):2444-54.

Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: A review. Drugs in Context. 2020;9:1-12.

Azer S. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes and New Infections. 2020;37:100738.

Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla DE, Zubair AS. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurol. 2020;77(8):1018.

World Health Organization. Transmission of SARS-CoV-2: Implications for infection prevention precautions [Internet]. 2020. Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions

McIntosh K, Hirsch M, Bloom A. COVID-19: Clinical features. UpToDate [Internet]. 2021 [cited 27 March 2021]. Available from: https://www.uptodate.com/contents/covid-19-clinical-features

Tsai P, Lai W, Lin Y, Luo Y, Lin Y, Chen H, et al. Clinical manifestation and disease progression in COVID-19 infection. J Chinese Med Assoc. 2020;84(1):3-8.

Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/394/2019 tentang Pedoman Nasional Pelayanan Kedokteran Tatalaksana Stroke. 2019.

Li Y, Wang M, Zhou Y, Chang J, Xian Y, Wang D, et al. Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study. SSRN Electronic Journal. 2020;5:e000431. DOI: 10.1136/svn-2020-000431

Yaghy S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51:00-00. DOI: 10.1161/STROKEAHA.120.030335

Khandelwal P, Al-Mufti F, Tiwari A, Singla A, Dmytriw A, Piano M, et al. Incidence, characteristics and outcomes of large vessel stroke in Covid-19: An International Multicenter Study. Neurosurg. 2021:89(1):35-41.

Fridman S, Bullrich MB, Ruiz AJ, Costantini P, Shah P, Just C, et al. Stroke risk, phenotypes, and death in COVID-19 – systematic review and newly reported cases. Neurology 2020;95(24):3373-85.DOI: 10.1212/WNL.0000000000010851.

Qureshi AD, Baskett WI, Huang W, Shyu D, Myers D, Raju M, et al. Acute ischemic stroke and COVID-19 an analysis of 27676 patients. Stroke 2021;52:905–12. DOI:10.1161/STROKEAHA.120.031786

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology 2020;77(6):683. DOI: 10.1001/jamaneurol.2020.1127

Katz JM, Libman RB, Wang JJ, Sanelli P, Filippi CG, Gribko M, et al. Cerebrovascular complications of COVID-19. Stroke 2020;51:227–31. DOI: 10.1161/STROKEAHA.120.031265

Altable M, de la Serna J. Cerebrovascular disease in COVID-19: Is there a higher risk of stroke? Brain Behav Immun Health. 2020;6:100092.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet 2020;395(10229):1054-62.

Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020;29(8):104984 DOI:10.1016

Mishra S, Choueka M, Wang Q, Hu C, Visone S, Silver M, et al. Intracranial hemorrhage in COVID-19 patients. J Stroke Cerebrovasc Dis. 2021;30(4):105603.

Srivastava PK, Zhang S, Xian Y, Xu H, Rutan C, Alger HM, et al. Acute ischemic stroke in patients with COVID-19. Stroke 2021;52:00-00.

Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and cerebrovascular diseases: A systematic review and perspectives for stroke management. Frontiers in Neurology 2020;11:574694. DOI: 10.3389/fneur.2020.574694.

Perry R, Smith C, Roffe C, Simister R, Narayanamoorthi S, Marigold R, et al. Characteristics and outcomes of COVID-19 associated stroke: A UK multicentre case-control study. J Neurol Neurosurg Psychiatr. 2020;92(3):242-8.

Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla DE, Spudich S, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019. JAMA Neurology. 2020;77(8):1018.

Lengkong, Warouw F, Kembuan M. Penanganan stroke iskemik akut di masa pandemi COVID-19. ECliniC. 2021;9(1):224-30.

Paliwal P, Tan B, Leow A, Sibi S, Chor D, Chin A, et al. Impact of the Covid-19 pandemic on hyperacute stroke treatment: Experience from a comprehensive stroke centre in Singapore. Stroke 2021;52.

Baracchini C, Pieroni A, Viaro F, Cianci V, Cattelan A, Tiberio I, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci. 2020;41(5):1003-5.

Rinkel LA, Prick JCM, Sombroek NMA, Sombroek NMA, Burggraaff J, Groot AE, et al. Impact of the COVID-19 outbreak on acute stroke care. J Neurol. 2021;268(2):403–8.

AHA/ASA. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic. Stroke. 2020;51(6):1910-2.

Diterbitkan

2021-08-02

Cara Mengutip

Hamidjoyo, B. P., & Wreksoatmodjo, B. R. (2021). Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Insidens dan Tatalaksana Penyakit Serebrovaskular. Cermin Dunia Kedokteran, 48(8), 283–288. https://doi.org/10.55175/cdk.v48i8.109